CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹245 Cr | ₹265 Cr | ₹246 Cr | ₹207 Cr | ₹167 Cr |
What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹246 Cr |
| Mar2022 | ₹207 Cr |
| Mar2021 | ₹167 Cr |
How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹245 Cr | -7.89 | |
| Mar2024 | ₹265 Cr | 7.91 | |
| Mar2023 | ₹246 Cr | 18.57 | |
| Mar2022 | ₹207 Cr | 24.37 | |
| Mar2021 | ₹167 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,939.0 Cr | -2.8% | -2.2% | -30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -2.8% |
-2.2% |
-30.2% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses